PTC
TARS icon

Private Trust Company’s Tarsus Pharmaceuticals TARS Stock Holding History

Private Trust Company’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78K Hold
60
– – ﹤0.01% 2367
2026
Q1 		$4.21K Sell
60
-24
-29% -$1.68K ﹤0.01% 2233
2025
Q4 		$6.88K Sell
84
-24
-22% -$1.79K ﹤0.01% 2062
2025
Q3 		$6.42K Hold
108
– – ﹤0.01% 2072
2025
Q2 		$4.38K Buy
+108
New +$4.86K ﹤0.01% 2099
2024
Q4 		– Sell
-79
Closed -$2.6K – 2409
2024
Q3 		$2.6K Buy
+79
New +$2.22K ﹤0.01% 2122

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Private Trust Company's TARS Position: Q2 2026 in Review

Private Trust Company held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 60 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Private Trust Company first reported a position in TARS in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.88K in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Private Trust Company held 60 shares of Tarsus Pharmaceuticals worth $3.78K as of Q2 2026.
  • Private Trust Company left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2367 holding.
  • Private Trust Company first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Private Trust Company's Tarsus Pharmaceuticals position peaked at $6.88K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.